Skip to main navigation
Go to Cumberland Pharmaceuticals, Inc. homepage
  • About Us
    • Profile & Mission
    • Our Strategy
    • Board of Directors
    • Management Team
    • Company History
  • Our Products
    • Commercial Products
    • Pipeline Products
    • International Partners
  • Investor Relations
    • Overview
    • Corporate Update
    • Corporate Governance
      • Committee Composition
      • Contact the Board
    • Stock Information
      • Historic Price Lookup
      • Ownership Profile
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Quarterly Results
      • Key Ratios
    • Earnings Calls & Presentations
    • Investor FAQs
    • Press Releases
    • Contact Investor Relations
  • News
  • Cumberland Emerging Technologies
  • Blog
  • About Us
    • Profile & Mission
    • Our Strategy
    • Board of Directors
    • Management Team
    • Company History
  • Our Products
    • Commercial Products
    • Pipeline Products
    • International Partners
  • Investor Relations
    • Overview
    • Corporate Update
    • Corporate Governance
      • Committee Composition
      • Contact the Board
    • Stock Information
      • Historic Price Lookup
      • Ownership Profile
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Quarterly Results
      • Key Ratios
    • Earnings Calls & Presentations
    • Investor FAQs
    • Press Releases
    • Contact Investor Relations
  • News
  • Cumberland Emerging Technologies
  • Blog
Contact
Contact

Quarterly Results

Show all

2025

Fourth Quarter
  • Cumberland Pharmaceuticals Reports 31% Fourth Quarter 2025 Revenue Growth
Third Quarter
  • Cumberland Pharmaceuticals Reports 12% Year-to-Date Revenue Growth
Second Quarter
  • Cumberland Pharmaceuticals Reports 23% Revenue Growth Year-to-Date
First Quarter
  • Cumberland Pharmaceuticals Reports 38% Revenue Growth in Q1 2025

2024

Fourth Quarter
  • Cumberland Pharmaceuticals Reports 11.6% Fourth Quarter 2024 Revenue Growth
Third Quarter
  • Cumberland Pharmaceuticals Reports Third Quarter 2024 Financial Results and Company Update
Second Quarter
  • Cumberland Pharmaceuticals Reports 16% Sequential Revenue Growth in Second Quarter 2024
First Quarter
  • Cumberland Pharmaceuticals Reports First Quarter 2024 Financial Results & Company Update

2023

Fourth Quarter
  • Cumberland Pharmaceuticals Reports Annual 2023 Financial Results
Third Quarter
  • Cumberland Pharmaceuticals Reports Third Quarter 2023 Financial Results
Second Quarter
  • Cumberland Pharmaceuticals Reports Revenue and Earnings Growth Second Quarter 2023
First Quarter
  • Cumberland Pharmaceuticals Reports First Quarter 2023 Financial Results & Company Update

© 2026 Cumberland Pharmaceuticals, Inc. All Rights Reserved.

Privacy Policy
Accessibility Statement
Terms of Use